The CMYA5 gene confers risk for both schizophrenia and major depressive disorder in the Han Chinese population

References

• Barrett JC, Fry B, Maller J, Daly M. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265.
   PubMed Web of Science ®Google Scholar
• Benson MA, Tinsley CL, Blake DJ. 2004. Myospryn is a novel binding partner for dysbindin in muscle. J Biol Chem 279: 10450–10458.
   Google Scholar
• Chen X, Lee G, Maher B, Fanous A, Chen J, Zhao Z, et al. 2010. GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol Psychiatry 16:1117–1129.
   Google Scholar
• Faul F, Erdfelder E, Lang A-G, Buchner A. 2007. G* Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39: 175–191.
   PubMed Web of Science ®Google Scholar
• Furukawa M, Tochigi M, Otowa T, Arinami T, Inada T, Ujike H, et al. 2013. An association analysis of the cardiomyopathy- associated 5 (CMYA5) gene with schizophrenia in a Japanese population. Psychiatr Genet 23:179–180.
   Google Scholar
• Ghiani C, Starcevic M, Rodriguez-Fernandez I, Nazarian R, Cheli V, Chan L, et al. 2009. The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth. Mol Psychiatry 15:204–215.
   Google Scholar
• Ghiani CA, Dell’Angelica EC. 2011. Dysbindin-containing complexes and their proposed functions in brain: from zero to (too) many in a decade. ASN neuro 3:109–124.
   Google Scholar
• Gokhale A, Larimore J, Werner E, So L, Moreno-De-Luca A, Lese-Martin C, et al. 2012. Quantitative proteomic and genetic analyses of the schizophrenia susceptibility factor dysbindin identify novel roles of the biogenesis of lysosome-related organelles complex 1. J Neurosci 32:3697–3711.
   PubMed Web of Science ®Google Scholar
• Gong J, Tong Y, Zhang HM, Wang K, Hu T, Shan G, et al. 2012. Genome‐wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat 33:254–263.
   PubMed Web of Science ®Google Scholar
• Green E, Grozeva D, Jones I, Jones L, Kirov G, Caesar S, et al. 2009. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 15:1016–1022.
   PubMed Web of Science ®Google Scholar
• Huang H-T, Brand OM, Mathew M, Ignatiou C, Ewen EP, Mccalmon SA, et al. 2006. Myomaxin Is a novel transcriptional target of MEF2A that encodes a Xin-related α-actinin- interacting protein. J Biol Chem 281:39370–39379.
   Google Scholar
• Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. 2005. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593–602.
   PubMed Web of Science ®Google Scholar
• Lee S, Tsang A, Zhang M-Y, Huang Y-Q, He Y-L, Liu Z-R, et al. 2007. Lifetime prevalence and inter-cohort variation in DSM-IV disorders in metropolitan China. Psychol Med 37:61–72.
   PubMedGoogle Scholar
• Li M, Luo X-j, Zhang X, Yang Z-h, Xiang K, Xiao X, et al. 2011. A common variant of the cardiomyopathy associated 5 gene (CMYA5) is associated with schizophrenia in Chinese population. Schizophr Res 129:217–219.
   Google Scholar
• Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, et al. 2009. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn).Cell Res 19:519–523.
   PubMed Web of Science ®Google Scholar
• Liu Y, Blackwood DH, Caesar S, de Geus EJ, Farmer A, Ferreira MA, et al. 2011. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry 16:2–4.
   PubMed Web of Science ®Google Scholar
• Morris DW, Murphy K, Kenny N, Purcell SM, McGhee KA, Schwaiger S, et al. 2008. Dysbindin (DTNBP1) and the biogenesis of lysosome-related organelles complex 1 (BLOC-1): main and epistatic gene effects are potential contributors to schizophrenia susceptibility. Biol Psychiatry 63:24–31.
   PubMed Web of Science ®Google Scholar
• Murphy JM, Laird NM, Monson RR, Sobol AM, Leighton AH. 2000. A 40-year perspective on the prevalence of depression: the Stirling County Study. Arch Gen Psychiatry 57:209–215.
   PubMed Web of Science ®Google Scholar
• Pritchard JK, Stephens M, Rosenberg NA, Donnelly P. 2000. Association mapping in structured populations. Am J Hum Genet 67:170–181.
   PubMed Web of Science ®Google Scholar
• Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, Sullivan PF, et al. 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460:748–752.
   PubMed Web of Science ®Google Scholar
• Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln SJ, et al. 2008. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 17:3631–3642.
   PubMed Web of Science ®Google Scholar
• Reynolds JG, McCalmon SA, Donaghey JA, Naya FJ. 2008. Deregulated protein kinase A signaling and myospryn expression in muscular dystrophy. J Biol Chem 283:8070–8074.
   Google Scholar
• Reynolds JG, McCalmon SA, Tomczyk T, Naya FJ. 2007. Identification and mapping of protein kinase A binding sites in the costameric protein myospryn. Biochim Biophys Acta 1773:891–902.
   Google Scholar
• Shi Y, He L. 2005. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15: 97–98.
   PubMed Web of Science ®Google Scholar
• Somers JM, Goldner EM, Waraich P, Hsu L. 2006. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can J Psychiatry 51:100–113.
   PubMed Web of Science ®Google Scholar
• Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, et al. 2002. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 71:337–348.
   PubMed Web of Science ®Google Scholar
• Tkatchenko AV, Piétu G, Cros N, Gannoun-Zaki L, Auffray C, Léger JJ, et al. 2001. Identification of altered gene expression in skeletal muscles from Duchenne muscular dystrophy patients. Neuromuscul Disord 11:269–277.
   Google Scholar
• Xiang Y-T, Ma X, Cai Z-J, Li S-R, Xiang Y-Q, Guo H-L, et al. 2008. Prevalence and socio-demographic correlates of schizophrenia in Beijing, China. Schizophr Res 102:270–277.
   PubMed Web of Science ®Google Scholar
• Yu W, Clyne M, Khoury MJ, Gwinn M. 2010. Phenopedia and Genopedia: disease-centered and gene-centered views of the evolving knowledge of human genetic associations. Bioinformatics 26:145–146.
   PubMed Web of Science ®Google Scholar
• Zhang R, Zhang H, Li M, Li H, Li Y, Valenzuela R, et al. 2013. Genetic analysis of common variants in the CMYA5 (cardiomyopathy-associated 5) gene with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 46:64–69.
   Google Scholar